In fact, the use of TNF-blocking agents has been associated with a more favorable response to pneumococcal vaccination in patients with autoimmune diseases compared to other immunosuppressive medication such as methotrexate, azathioprine or rituximab [34]. The gene discussed is TNF; the disease is autoimmune disease.